Secondary findings in genes related to cancer phenotypes in Turkish exome sequencing data from 2020 individuals

Author:

Demir Oguzhan1,Saglam Kubra Adanur1,Yilmaz Mustafa1,Apuhan Tuna1,Cebi Alper Han1,Turkyilmaz Ayberk1ORCID

Affiliation:

1. Department of Medical Genetics, Faculty of Medicine Karadeniz Technical University Trabzon Turkey

Abstract

AbstractBig data generated from exome sequencing (ES) and genome sequencing (GS) analyses can be used to detect actionable and high‐penetrance variants that are not directly associated with the primary diagnosis of patients but can guide their clinical follow‐up and treatment. Variants that are classified as pathogenic/likely pathogenic and are clinically significant but not directly associated with the primary diagnosis of patients are defined as secondary findings (SF). The aim of this study was to examine the frequency and variant spectrum of cancer‐related SF in 2020 Turkish ES data and to discuss the importance of the presence of cancer‐related SF in at‐risk family members in terms of genetic counseling and follow‐up. A total of 2020 patients from 2020 different families were evaluated by ES. SF were detected in 28 unrelated cases (1.38%), and variants in BRCA2 (11 patients) and MLH1 (4 patients) genes were observed most frequently. A total of 21 different variants were identified, with 4 of them (c.9919_9932del and c.3653del in the BRCA2 gene, c.2002A>G in the MSH2 gene, c.26_29del in the TMEM127 gene) being novel variations. In three different families, c.1189C>T (p.Gln397*) variation in BRCA2 gene was detected, suggesting that this may be a common variant in the Turkish population. This study represents the largest cohort conducted in the Turkish population, examining the frequency and variant spectrum of cancer‐related SF. With the identification of frequent variations and the detection of novel variations, the findings of this study have contributed to the variant spectrum. Genetic testing conducted in family members is presented as real‐life data, showcasing the implications in terms of counseling, monitoring, and treatment through case examples.

Publisher

Wiley

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3